Cargando…

Identifying priority medicines policy issues for New Zealand: a general inductive study

OBJECTIVES: To identify priority medicines policy issues for New Zealand. SETTING: Stakeholders from a broad range of healthcare and policy institutions including primary, secondary and tertiary care. PARTICIPANTS: Exploratory, semistructured interviews were conducted with 20 stakeholders throughout...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babar, Zaheer-Ud-Din, Francis, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039830/ https://www.ncbi.nlm.nih.gov/pubmed/24871535 http://dx.doi.org/10.1136/bmjopen-2013-004415

Ejemplares similares

Identifying priority medicines policy issues for Qatar: exploring perspectives and experiences of healthcare professionals through a qualitative study
por: Zia, Nadeem, et al.
Publicado: (2021)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2012)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

Policy cooperation and interface issues
por: Vogler, Sabine, et al.
Publicado: (2015)

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

New Zealand’s Drug Development Industry
por: Lockhart, Michelle Marie, et al.
Publicado: (2013)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Understanding children’s perceptions of, and priorities for, healthy neighbourhoods in Aotearoa New Zealand: study protocol for a cross-sectional study
por: Egli, Victoria, et al.
Publicado: (2021)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
por: Mirza, Ahmer Hameed, et al.
Publicado: (2023)

Modified Policy-Delphi study for exploring obesity prevention priorities
por: Haynes, Emily, et al.
Publicado: (2016)

New Zealand consumers’ perceptions of private insurance for pharmaceuticals
por: Ragupathy, Rajan, et al.
Publicado: (2014)

A Framework for Improving Policy Priorities in Managing COVID-19 Challenges in Developing Countries
por: Rasul, Golam
Publicado: (2020)

Priorities and Instruments of Local Elderly Care Policies in China: Text Mining and Comparative Analysis
por: Li, Xiuqi, et al.
Publicado: (2021)

Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries?
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2010)

The shift of percent excess mortality from zero-COVID policy to living-with-COVID policy in Singapore, South Korea, Australia, New Zealand and Hong Kong SAR
por: Cao, Xiaohan, et al.
Publicado: (2023)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

Actual Causes of Death in Relation to Media, Policy, and Funding Attention: Examining Public Health Priorities
por: Pilar, Meagan R., et al.
Publicado: (2020)

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Policies beyond the crisis: lesson learned
por: Vogler, Sabine, et al.
Publicado: (2015)

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries
por: Gammie, Todd, et al.
Publicado: (2015)

Adolescent Obesity Prevention in Saudi Arabia: Co-identifying Actionable Priorities for Interventions
por: Almughamisi, Manal, et al.
Publicado: (2022)

Southern Med Review to Journal of Pharmaceutical Policy and Practice: broadening the remit!
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2013)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Health needs as a priority of local authorities in Poland based on the example of implementation of health policy cancer programmes
por: Augustynowicz, Anna, et al.
Publicado: (2016)

Identifying hearing care access barriers among older Pacific Island people in New Zealand: a qualitative study
por: Reddy, Ravi, et al.
Publicado: (2019)

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies
por: Scahill, Shane, et al.
Publicado: (2012)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Medicines and universal health coverage: challenges and opportunities
por: Bigdeli, Maryam, et al.
Publicado: (2015)

Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2015)

Under-reporting of maternal and perinatal adverse events in New Zealand
por: Farquhar, Cynthia, et al.
Publicado: (2015)

Profiling the New Zealand Police Trainee Physical Competency Test
por: Dawes, J. Jay, et al.
Publicado: (2022)

Our health, our research. Identifying public health research priorities among children and youth in a multiethnic population: protocol for a community-based participatory health research priority survey
por: Irgens, Eirik Lind, et al.
Publicado: (2023)

Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine
por: Fortin, Davide, et al.
Publicado: (2022)

The Need for an Evidence-Based Encyclopaedia in Health Services Research in Pharmacy
por: Babar, Zaheer-Ud-Din
Publicado: (2020)

Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
por: Babar, Zaheer-Ud-Din
Publicado: (2021)

Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
por: Mattila, Phyllis Ocran, et al.
Publicado: (2021)

A comprehensive survey of cancer medicines prices, availability and affordability in Ghana
por: Ocran Mattila, Phyllis, et al.
Publicado: (2023)

Leading Causes of Mortality and Prescription Drug Coverage in Canada and New Zealand
por: Rawson, Nigel S. B.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8q4193f6enb5m4r7mu4vibcv9v